Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin

Abstract Background Pleural mesothelioma (PM) is an aggressive malignancy with poor prognosis. Unlike many other cancers, PM is mostly characterized by inactivation of tumor suppressor genes. Its highly malignant nature in absence of tumor driving oncogene mutations indicates an extrinsic supply of...

Full description

Bibliographic Details
Main Authors: Alexander Ries, Daniela Flehberger, Astrid Slany, Christine Pirker, Johanna C. Mader, Thomas Mohr, Karin Schelch, Katharina Sinn, Berta Mosleh, Mir Alireza Hoda, Balazs Dome, Helmut Dolznig, Georg Krupitza, Leonhard Müllauer, Christopher Gerner, Walter Berger, Michael Grusch
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13046-022-02582-0
_version_ 1811175666138218496
author Alexander Ries
Daniela Flehberger
Astrid Slany
Christine Pirker
Johanna C. Mader
Thomas Mohr
Karin Schelch
Katharina Sinn
Berta Mosleh
Mir Alireza Hoda
Balazs Dome
Helmut Dolznig
Georg Krupitza
Leonhard Müllauer
Christopher Gerner
Walter Berger
Michael Grusch
author_facet Alexander Ries
Daniela Flehberger
Astrid Slany
Christine Pirker
Johanna C. Mader
Thomas Mohr
Karin Schelch
Katharina Sinn
Berta Mosleh
Mir Alireza Hoda
Balazs Dome
Helmut Dolznig
Georg Krupitza
Leonhard Müllauer
Christopher Gerner
Walter Berger
Michael Grusch
author_sort Alexander Ries
collection DOAJ
description Abstract Background Pleural mesothelioma (PM) is an aggressive malignancy with poor prognosis. Unlike many other cancers, PM is mostly characterized by inactivation of tumor suppressor genes. Its highly malignant nature in absence of tumor driving oncogene mutations indicates an extrinsic supply of stimulating signals by cells of the tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) are an abundant cell type of the TME and have been shown to drive the progression of several malignancies. The aim of the current study was to isolate and characterize patient-derived mesothelioma-associated fibroblasts (Meso-CAFs), and evaluate their impact on PM cells. Methods Meso-CAFs were isolated from surgical specimens of PM patients and analyzed by array comparative genomic hybridization, next generation sequencing, transcriptomics and proteomics. Human PM cell lines were retrovirally transduced with GFP. The impact of Meso-CAFs on tumor cell growth, migration, as well as the response to small molecule inhibitors, cisplatin and pemetrexed treatment was investigated in 2D and 3D co-culture models by videomicroscopy and automated image analysis. Results Meso-CAFs show a normal diploid genotype without gene copy number aberrations typical for PM cells. They express CAF markers and lack PM marker expression. Their proteome and secretome profiles clearly differ from normal lung fibroblasts with particularly strong differences in actively secreted proteins. The presence of Meso-CAFs in co-culture resulted in significantly increased proliferation and migration of PM cells. A similar effect on PM cell growth and migration was induced by Meso-CAF-conditioned medium. Inhibition of c-Met with crizotinib, PI3K with LY-2940002 or WNT signaling with WNT-C59 significantly impaired the Meso-CAF-mediated growth stimulation of PM cells in co-culture at concentrations not affecting the PM cells alone. Meso-CAFs did not provide protection of PM cells against cisplatin but showed significant protection against the EGFR inhibitor erlotinib. Conclusions Our study provides the first characterization of human patient-derived Meso-CAFs and demonstrates a strong impact of Meso-CAFs on PM cell growth and migration, two key characteristics of PM aggressiveness, indicating a major role of Meso-CAFs in driving PM progression. Moreover, we identify signaling pathways required for Meso-CAF-mediated growth stimulation. These data could be relevant for novel therapeutic strategies against PM.
first_indexed 2024-04-10T19:39:25Z
format Article
id doaj.art-0584feb1baa7455e98b30e32f6b10aef
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-04-10T19:39:25Z
publishDate 2023-01-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-0584feb1baa7455e98b30e32f6b10aef2023-01-29T12:24:40ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662023-01-0142112010.1186/s13046-022-02582-0Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatinAlexander Ries0Daniela Flehberger1Astrid Slany2Christine Pirker3Johanna C. Mader4Thomas Mohr5Karin Schelch6Katharina Sinn7Berta Mosleh8Mir Alireza Hoda9Balazs Dome10Helmut Dolznig11Georg Krupitza12Leonhard Müllauer13Christopher Gerner14Walter Berger15Michael Grusch16Center for Cancer Research and Comprehensive Cancer Center, Medical University of ViennaCenter for Cancer Research and Comprehensive Cancer Center, Medical University of ViennaDepartment of Analytical Chemistry, University of ViennaCenter for Cancer Research and Comprehensive Cancer Center, Medical University of ViennaDepartment of Analytical Chemistry, University of ViennaCenter for Cancer Research and Comprehensive Cancer Center, Medical University of ViennaCenter for Cancer Research and Comprehensive Cancer Center, Medical University of ViennaDepartment of Thoracic Surgery, Medical University of ViennaDepartment of Thoracic Surgery, Medical University of ViennaDepartment of Thoracic Surgery, Medical University of ViennaDepartment of Thoracic Surgery, Medical University of ViennaInstitute of Medical Genetics, Medical University of ViennaDepartment of Clinical Pathology, Medical University of ViennaDepartment of Clinical Pathology, Medical University of ViennaDepartment of Analytical Chemistry, University of ViennaCenter for Cancer Research and Comprehensive Cancer Center, Medical University of ViennaCenter for Cancer Research and Comprehensive Cancer Center, Medical University of ViennaAbstract Background Pleural mesothelioma (PM) is an aggressive malignancy with poor prognosis. Unlike many other cancers, PM is mostly characterized by inactivation of tumor suppressor genes. Its highly malignant nature in absence of tumor driving oncogene mutations indicates an extrinsic supply of stimulating signals by cells of the tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) are an abundant cell type of the TME and have been shown to drive the progression of several malignancies. The aim of the current study was to isolate and characterize patient-derived mesothelioma-associated fibroblasts (Meso-CAFs), and evaluate their impact on PM cells. Methods Meso-CAFs were isolated from surgical specimens of PM patients and analyzed by array comparative genomic hybridization, next generation sequencing, transcriptomics and proteomics. Human PM cell lines were retrovirally transduced with GFP. The impact of Meso-CAFs on tumor cell growth, migration, as well as the response to small molecule inhibitors, cisplatin and pemetrexed treatment was investigated in 2D and 3D co-culture models by videomicroscopy and automated image analysis. Results Meso-CAFs show a normal diploid genotype without gene copy number aberrations typical for PM cells. They express CAF markers and lack PM marker expression. Their proteome and secretome profiles clearly differ from normal lung fibroblasts with particularly strong differences in actively secreted proteins. The presence of Meso-CAFs in co-culture resulted in significantly increased proliferation and migration of PM cells. A similar effect on PM cell growth and migration was induced by Meso-CAF-conditioned medium. Inhibition of c-Met with crizotinib, PI3K with LY-2940002 or WNT signaling with WNT-C59 significantly impaired the Meso-CAF-mediated growth stimulation of PM cells in co-culture at concentrations not affecting the PM cells alone. Meso-CAFs did not provide protection of PM cells against cisplatin but showed significant protection against the EGFR inhibitor erlotinib. Conclusions Our study provides the first characterization of human patient-derived Meso-CAFs and demonstrates a strong impact of Meso-CAFs on PM cell growth and migration, two key characteristics of PM aggressiveness, indicating a major role of Meso-CAFs in driving PM progression. Moreover, we identify signaling pathways required for Meso-CAF-mediated growth stimulation. These data could be relevant for novel therapeutic strategies against PM.https://doi.org/10.1186/s13046-022-02582-0Pleural mesotheliomaCancer-associated fibroblastsCo-culturesTumor microenvironmentWNTPI3K
spellingShingle Alexander Ries
Daniela Flehberger
Astrid Slany
Christine Pirker
Johanna C. Mader
Thomas Mohr
Karin Schelch
Katharina Sinn
Berta Mosleh
Mir Alireza Hoda
Balazs Dome
Helmut Dolznig
Georg Krupitza
Leonhard Müllauer
Christopher Gerner
Walter Berger
Michael Grusch
Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
Journal of Experimental & Clinical Cancer Research
Pleural mesothelioma
Cancer-associated fibroblasts
Co-cultures
Tumor microenvironment
WNT
PI3K
title Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
title_full Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
title_fullStr Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
title_full_unstemmed Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
title_short Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
title_sort mesothelioma associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c met pi3k and wnt signaling but do not protect against cisplatin
topic Pleural mesothelioma
Cancer-associated fibroblasts
Co-cultures
Tumor microenvironment
WNT
PI3K
url https://doi.org/10.1186/s13046-022-02582-0
work_keys_str_mv AT alexanderries mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT danielaflehberger mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT astridslany mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT christinepirker mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT johannacmader mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT thomasmohr mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT karinschelch mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT katharinasinn mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT bertamosleh mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT miralirezahoda mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT balazsdome mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT helmutdolznig mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT georgkrupitza mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT leonhardmullauer mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT christophergerner mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT walterberger mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin
AT michaelgrusch mesotheliomaassociatedfibroblastsenhanceproliferationandmigrationofpleuralmesotheliomacellsviacmetpi3kandwntsignalingbutdonotprotectagainstcisplatin